key: cord-0849405-w9mq30cu authors: Rizer, Nicholas W.; Smood, Benjamin; Mergler, Blake; Sperry, Alexandra E.; Bermudez, Christian A.; Gutsche, Jacob T.; Usman, Asad A. title: Reduced Survival in Patients Requiring Chest Tubes with COVID-19 Acute Respiratory Distress Syndrome date: 2022-04-20 journal: JTCVS Open DOI: 10.1016/j.xjon.2022.03.008 sha: 9c3b05baa6782f8d69c8982ef187d44f9a48388f doc_id: 849405 cord_uid: w9mq30cu Background Numerous complications requiring tube thoracostomy have been reported among critically ill COVID-19 patients, however, there has been a lack of evidence regarding outcomes following chest tube placement. Methods We developed a retrospective observational cohort of all patients admitted to an intensive care unit (ICU) with confirmed COVID-19 to describe the incidence of tube thoracostomy and factors associated with mortality following chest tube placement. Results In total, 1,705 patients with laboratory confirmed COVID-19 patients were admitted to our ICUs from March 7, 2020 to March 1, 2021, with 69/1705 patients (4.0%) receiving 130 chest tubes. Of these 89/130 (68%) chest tubes were indicated for pneumothorax. Patients receiving tube thoracostomy were much less likely to be alive 90 days post-ICU admission (52% vs 69%, p < 0.01), and had longer ICU (30 vs 5 days, p < 0.01) and hospital (37 vs 10 days, p < 0.01) lengths of stay compared to those without tube thoracostomy. Patients who received tube thoracostomy and survived at least 90 days post-ICU admission had shorter times to first chest tube insertion (8.5 vs 17.0 days, p = 0.01) and a non-significantly higher static compliance (20.0 vs 17.5 mL/cm H2O, p = 0.052) at the time of chest tube placement than those who had expired. Logistic regression analysis demonstrated an association between time to first chest tube and decreased survival when adjusted for covariates. Conclusions Requiring a chest tube in COVID 19 is a negative prognostic endpoint. Delayed development of chest tube requirement was associated with a decreased survival and could reflect a poor healing phenotype. IRB/Consent: This study was reviewed and approved on 05/20/2020 by the University of 23 Pennsylvania IRB (#842836) and the requirement for informed consent was waived due to 24 minimal risk to subjects and retrospective chart review only. 25 Acknowledgments 26 We would like to the thank the Clinical Research Informatics Core the University of 27 Pennsylvania Health System for the querying and collection of patient information from our 28 EHR. The mapping of ICD-10 codes to Charlson comorbidity index values was adapted from 29 https://github.com/chvlyl/Comorbidity_Index. 30 J o u r n a l P r e -p r o o f course for so-called COVID-19 acute respiratory distress syndrome (ARDS) is dynamic and is 105 believed to progress from a high compliance phenotype to a low compliance phenotype. 21 106 Failure to adequately appreciate how COVID ARDS differs from "typical" ARDS and recognize its 107 transition from the compliant to stiff phenotype could expose patients to underappreciated 108 barotrauma and resultant pneumothorax. The increased risk for secondary bacterial infections 109 in COVID-19 patients may also contribute to increased lung injury. 22 Furthermore, there is a lack 110 of consensus on ventilator management and lung rest in COVID ARDS and how to prevent 111 further lung injury. Despite this unique potential for serious lung injury in COVID ARDS, there is 112 scant evidence regarding the clinical course of patients following tube thoracostomy. 23 In this 113 study we sought to characterize the clinical course of critically ill COVID-19 patients with chest 114 tubes to better understand the implications on morbidity and mortality. We present a 115 retrospective cohort study describing all COVID-19 patients admitted to our ICU who 116 underwent tube thoracostomy in a large multi-hospital health care system. 117 Demographic factors for patients with and without tube thoracostomy are presented in Table 1 . Table 3 ). 90% (62/69) of patients with tube 209 thoracostomy required mechanical ventilation during admission, a significantly increased 210 incidence than among patients without tube thoracostomy (See Table 4 This data highlights that patients who require a chest tube for pneumothorax represent a 237 diseased lung, in which those patients with pneumothorax will have higher mortality in critically 238 ill COVID-19 patients (Figure 2 ). Patients who receive chest tubes have increased mortality, long 239 duration of mechanical ventilation, and hospital and ICU length of stay compared to those 240 patients who did not develop a pneumothorax requiring chest tube placement. Additionally, we 241 were able to estimate the prevalence of tube thoracostomy (4.0%) in COVID-19 ICU patients 242 and describe the indications for chest tube placement. Our work also suggests a novel metric to 243 aid in prognostication among COVID-19 patients who require tube thoracostomies. That is 244 prolonged ICU stay before requiring tube thoracostomy may reflect worse underlying lung 245 pathology than patients with requirement of chest tube early in their ICU stay. 246 The 90 day-post-ICU admission mortality rate for our population of patients (31% vs 31%) was 248 similar to another large European ICU cohort. 25 Furthermore, our work is concordant with 249 previous literature suggesting that pneumothorax is a common and distinct risk in COVID-19 250 patients, with pneumothorax representing the majority of our indications for chest tube. 26,27 251 Although previous studies suggested that pneumothorax was not a negative prognostic sign in 252 COVID-19 patients, our work shows this finding may not extend to critically ill populations as 253 our patients with pneumothorax had lower survival rates at 90 days. 6 Our work is not without limitations. As this is a retrospective observational analysis on a large, 280 incomplete dataset we cannot eliminate the possibility of non-random missing or incorrectly 281 labeled observations. We were unable to include a measure of disease severity as SOFA and 282 APACHE-II scores were not readily available or calculable for many of our patients. Presence of chest tubes, mortality, and other clinical parameters were collected. Implication: Tube thoracostomy in critically-ill COVID-19 patients is a negative prognostic sign. Keywords: Critical Care; Mechanical Ventilation Coronavirus disease (COVID-19) Clinical characteristics and imaging manifestations of the 2019 299 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city Clinical course and outcomes of critically ill patients with SARS-302 CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Coronavirus Disease 2019 (COVID-305 19): A Systematic Review of Imaging Findings in 919 Patients Pneumothorax in 308 COVID-19 disease-incidence and clinical characteristics Emergency tracheal intubation in 202 patients with COVID-311 19 in Wuhan, China: lessons learnt and international expert recommendations An evidence-based approach to drainage of the 314 pleural cavity: evaluation of best practice Pneumothorax in the critically ill patient Management of Pleural Infection. Pulm Ther Current State of Empyema 323 Management Thoracostomy tubes: A comprehensive review of 326 complications and related topics Analysis of Tube Thoracostomy Performed by Pulmonologists at 329 a Teaching Hospital Errors and Complications in Chest Tube Placement Tension pneumothorax in a patient with 333 COVID-19 Pleural Effusion as a Sign of 335 COVID-19) Pneumonia: A Case Report Clinical course of ICU patients 338 with severe pandemic 2009 influenza a (H1N1) pneumonia: Single center experience with 339 proning and pressure release ventilation Severe Acute Respiratory Syndrome Complicated by 342 Spontaneous Pneumothorax Chest Tube Drainage in the Age of COVID-19 Covid-19 Does Not Lead to a 347 "Typical" Acute Respiratory Distress Syndrome Incidence of co-infections and 350 superinfections in hospitalized patients with COVID-19: a retrospective cohort study Management of Respiratory Distress Syndrome due to 353 COVID-19 infection Coding Algorithms for Defining Comorbidities in 355 ICD-9-CM and ICD-10 Administrative Data: Med Care Clinical 358 characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a 359 prospective cohort study High incidence and mortality of pneumothorax in critically Ill 362 patients with COVID-19 Pneumothorax in critically ill patients with 364 COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control 365 multicenter study COVID-19 pneumonia: ARDS or not? Converging 372 pathways in pulmonary fibrosis and Covid-19 -The fibrotic link to disease severity Ventilator-induced Lung Injury Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping 377 review Driving Pressure and Survival in the Acute 379 Respiratory Distress Syndrome What links ventilator driving pressure with 382 survival in the acute respiratory distress syndrome? A computational study COVID-19-associated acute respiratory distress 385 syndrome: is a different approach to management warranted?